Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients

Abstract

We conclude that post-transplant glucose intolerance could be due to a dose-dependent, direct effect of FK506 on the pancreatic beta cell function, which can be controlled by dose reduction.